Stay updated on Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    A new page revision tag, Revision: v3.5.4, was added, replacing the prior Revision: v3.5.3 to reflect an update to the page's version.
    Difference
    0.1%
    Check dated 2026-05-15T07:40:36.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page’s footer revision/version indicator is updated from v3.5.2 to v3.5.3, reflecting a minor site release without changing the underlying study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:11:14.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:25:52.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:07:51.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.2 to v3.4.3. There are no changes to the displayed study details or page content.
    Difference
    0.1%
    Check dated 2026-03-12T00:24:39.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    A new site revision tag 'Revision: v3.4.2' was added. The deletions remove an operating-status notice and a prior revision tag ('Revision: v3.4.1'), which are administrative updates and do not change study content.
    Difference
    0.4%
    Check dated 2026-02-11T10:55:04.000Z thumbnail image

Stay in the know with updates to Nivolumab for Recurrent Rare CNS Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Recurrent Rare CNS Cancers Clinical Trial page.